Health Care & Life Sciences » Biotechnology | Cerenis Therapeutics Holding

Cerenis Therapeutics Holding S.A. | Ownership

Companies that own Cerenis Therapeutics Holding S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Gestys SA
60,000
0.32%
-20,000
2.08%
03/23/2018
Montaigne Capital SAS
40,000
0.21%
0
0.42%
08/31/2018
Meeschaert Asset Management SA
37,500
0.2%
9,500
0.01%
09/30/2016
Sycomore Asset Management SA
15,000
0.08%
0
0%
12/30/2016
Financière de l'Arc SAS
3,715
0.02%
3,715
0.01%
12/30/2016
Rothschild Asset Management SCS
1,640
0.01%
1,640
0%
12/31/2015
Allianz Global Investors GmbH (France)
820
0%
820
0%
12/31/2015
DNCA Finance SA
0
0%
-36,000
0%
06/30/2017
Amilton Asset Management SA
0
0%
-65,000
0%
06/30/2017

About Cerenis Therapeutics Holding

View Profile
Address
33-43, av. Georges Pompidou- Bât. D2
Balma Midi-Pyrenees 31130
France
Employees -
Website http://www.cerenis.com
Updated 07/08/2019
Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.